SCHEMBL30376178

SCHEMBL30376178

O=S(=O)(NCCCN1CCC(Cc2ccccc2)CC1)c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 3/20 0.69
MEN1 O00255 1/20 0.62
HTT P42858 1/20 0.62
KMT2A Q03164 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
CCR3 P51677 4/20 0.58
SIGMAR1 Q99720 2/20 0.58
SLC6A2 P23975 3/20 0.58
SLC6A3 Q01959 1/20 0.58
PRMT6 Q96LA8 2/20 0.56
CARM1 Q86X55 1/20 0.56
MAPT P10636 1/20 0.56
SLC6A4 P31645 2/20 0.56
KCNH2 Q12809 1/20 0.55
KDM4E B2RXH2 1/20 0.55
TMEM97 Q5BJF2 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24069429 0.93 SLC6A2 (0.63) HTR7MEN1HTTKMT2ASMN1; SMN2
SCHEMBL24070124 0.92 MEN1 (0.60) HTR7MEN1HTTKMT2ASMN1; SMN2
SCHEMBL25758331 0.90 MEN1 (0.58) HTR7MEN1HTTKMT2ASMN1; SMN2
SCHEMBL25290527 0.90 SLC6A2 (0.59) HTR7MEN1HTTKMT2ASMN1; SMN2
SCHEMBL25758537 0.89 HTR7 (0.58) HTR7MEN1HTTKMT2ASMN1; SMN2
SCHEMBL29022584 0.89 SMN1; SMN2 (0.57) HTR7MEN1HTTKMT2ASMN1; SMN2
SCHEMBL25758335 0.89 HTR7 (0.62) HTR7MEN1HTTKMT2ASMN1; SMN2
SCHEMBL25758526 0.89 CCR3 (0.58) HTR7MEN1HTTKMT2ASMN1; SMN2
SCHEMBL25758544 0.89 MEN1 (0.69) HTR7MEN1HTTKMT2ASMN1; SMN2
SCHEMBL25289791 0.88 HTR7 (0.73) HTR7MEN1HTTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4159718-A1 SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS Daegu-Gyeongbuk Medical Innovation Foundation (KR) 2023-04-05 EP disclosed